Skip to content
GLP-1 Desk
Menu
Dispatch #131

Layla

Layla is a US telehealth weight-loss program built around semaglutide, offering compounded semaglutide as injections and as oral dropper drops, plus compounded tirzepatide and a brand-inclusive GLP-1…

Visit Layla ↗Assume any provider we list may compensate us — we may earn a referral commission at no extra cost to you, and what we file on a provider reads the same either way.
Semaglutide
$237/mo (all doses, compounded)
Tirzepatide
$199/mo (all doses, compounded)
Coverage
Coverage not published
Brand-name
Yes

Weigh Layla against the full ranked field on the best semaglutide providers board, or line it up against its closest alternatives. Or go one-on-one: Layla vs CoreAge Rx.

Desk Score breakdown

Each of the six scored dimensions. See the methodology.

Price transparency94/100
State access24/100
Molecule range90/100
Onboarding speed63/100
Support responsiveness78/100
Licensing & trust65/100

What the Desk likes

  • Oral semaglutide dropper option plus injectable semaglutide and tirzepatide, with a brand-name upgrade path
  • Named Medical Director (Dr. Ruth Cohen) and 24-7 doctor messaging
  • Quiz-based intake with fast three to five day shipping

Where points come off

  • Brand-inclusive GLP-1 program is expensive, starting around 1,299 dollars
  • States served are not published on the site
  • Support phone line uses a UK format, and the compounding pharmacy is not named

The Desk's briefing — C

Best for: People wanting oral or injectable semaglutide with a brand-inclusive glp-1 upgrade path.

Layla ranks #131 of 498 providers scored — see #1, CoreAge Rx on the board.

Visit Layla ↗

Related dispatches

Everyone else on the board (18)

Pricing and verification reflect Layla's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on Layla's site. Not medical advice; see our disclosure.

← Back to The Desk